RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo

被引:51
|
作者
Chen, Yangchao [1 ]
Xie, Dan [2 ]
Li, Wing Yin
Cheung, Chi Man
Yao, Hong [3 ,4 ]
Chan, Ching Yu
Chan, Chu-yan [3 ,4 ]
Xu, Fang-Ping [5 ]
Liu, Yan-Hui [5 ]
Sung, Joseph J. Y. [6 ]
Kung, Hsiang-fu [3 ,4 ]
机构
[1] Chinese Univ Hong Kong, Sci Ctr N, Fac Med & Therapeut, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China
[2] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
[3] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, State Key Lab Oncol S China, Shatin, Hong Kong, Peoples R China
[5] Guangdong Prov Peoples Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China
[6] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
关键词
Enhancer of zeste homolog 2; Pancreatic cancer; Tumorigenecity; Liver metastasis; GROUP PROTEIN EZH2; POPULATION-BASED ANALYSIS; POLYCOMB-GROUP PROTEINS; OF-DEFENSE HOSPITALS; HEPATOCELLULAR-CARCINOMA; HEPATIC METASTASIS; DOWN-REGULATION; BREAST-CANCER; NUDE-MICE; EXPRESSION;
D O I
10.1016/j.canlet.2010.05.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The function of EZH2 in tumorigenesis and liver metastasis of pancreatic cancer has never been elucidated in vivo. EZH2 was overexpressed in pancreatic carcinomas and its overexpression was associated with tumor differentiation and pT status. Suppression of EZH2 caused a significant growth inhibition of pancreatic cancer cells in vitro and markedly diminished their tumorigenicity in vivo. Knock-down of EZH2 inhibited liver metastasis of pancreatic cancer in vivo. EZH2 has a crucial role in tumor growth and liver metastasis of pancreatic cancer. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [1] miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2
    Yu, Li
    Lu, Juan
    Zhang, Bao
    Liu, Xiong
    Wang, Lu
    Li, Si-Yang
    Peng, Xiao-Hong
    Xu, Xia
    Tian, Wen-Dong
    Li, Xiang-Ping
    ONCOLOGY LETTERS, 2013, 5 (04) : 1223 - 1228
  • [2] A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2
    Wang, Yan
    Ma, Jingyi
    Chow, Sheung Ching
    Li, Chi Han
    Xiao, Zhangang
    Feng, Ru
    Fu, Jie
    Chen, Yangchao
    TUMOR BIOLOGY, 2014, 35 (01) : 205 - 212
  • [3] Targeting EZH2 in cancer
    Kim, Kimberly H.
    Roberts, Charles W. M.
    NATURE MEDICINE, 2016, 22 (02) : 128 - 134
  • [4] MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma
    Zhang, Yuan
    Wang, Jiangang
    An, Wenzhi
    Chen, Chen
    Wang, Wencheng
    Zhu, Chao
    Chen, Fangzhou
    Chen, Huizhao
    Zheng, Wei
    Gong, Jie
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2019, 18
  • [5] Treating human cancer by targeting EZH2
    Xu, Mengfei
    Xu, Chunyan
    Wang, Rui
    Tang, Qing
    Zhou, Qichun
    Wu, Wanyin
    Wan, Xinliang
    Mo, Handan
    Pan, Jun
    Wang, Sumei
    GENES & DISEASES, 2025, 12 (03)
  • [6] Conditionally replicative adenovirus carrying shRNA targeting EZH2 inhibits prostate cancer growth and invasion
    Xu, Shi-Gao
    Yu, Jun-Jie
    Shi, Qun
    Niu, Quan
    Guo, Zhe
    Guo, Bao-Yu
    Zhou, Guang-Chen
    Gu, Xiao
    Wu, Yin-Xia
    ONCOLOGY REPORTS, 2019, 42 (01) : 273 - 282
  • [7] MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2
    Zhang, Yi
    Lin, Changwei
    Liao, Guoqing
    Liu, Sheng
    Ding, Jie
    Tang, Fang
    Wang, Zhenran
    Liang, Xingsi
    Li, Bo
    Wei, Yangchao
    Huang, Qi
    Li, Xuan
    Tang, Bo
    ONCOTARGET, 2015, 6 (32): : 32586 - 32601
  • [8] microRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2
    Yang, Yanling
    Liu, Yang
    Li, Guilin
    Li, Lei
    Geng, Peng
    Song, Hongjuan
    ONCOLOGY LETTERS, 2018, 16 (05) : 5679 - 5686
  • [9] Diosgenin exhibits tumor suppressive function via down-regulation of EZH2 in pancreatic cancer cells
    Guo, Wenhao
    Chen, Yujia
    Gao, Jinsheng
    Zhong, Kunhong
    Wei, Heng
    Li, Ke
    Tang, Mei
    Zhao, Xinyu
    Liu, Xinyu
    Nie, Chunlai
    Yuan, Zhu
    CELL CYCLE, 2019, 18 (15) : 1745 - 1758
  • [10] miR-498 inhibits the growth and metastasis of liver cancer by targeting ZEB2
    Zhang, Xu
    Xu, Xueying
    Ge, Guohong
    Zang, Xueyan
    Shao, Meng
    Zou, Shengqiang
    Zhang, Yu
    Mao, Zheying
    Zhang, Jiayin
    Mao, Fei
    Qian, Hui
    Xu, Wenrong
    ONCOLOGY REPORTS, 2019, 41 (03) : 1638 - 1648